A qualitative interview study exploring patient views and experiences of treatment for hidradenitis suppurativa in the UK

Further Publications Rheumatology

Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs

BMJ Open

Silverthorne CA, Jones B, Brooke M, Coates LC, Orme J, Robson JC, Tillett W, Dures E

doi: 10.1136/bmjopen-2023-075871

Atopic Dermatitis

A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register

Br J Dermatol

Alexander H, Malek R, Prieto-Merino D, Gribaleva E, Baden M, Beattie P, Brown S, Burton T, Cameron S, Coker B, Cork MJ, Hearn R, Ingram JR, Irvine AD, Johnston GA, Lambert A, Lunt M, Man I, Newell L, Ogg G, Patel P, Wan M, Warren RB, Woolf R, Yiu ZZN, Reynolds N, Ardern-Jones MR, Flohr C, UK-Irish A-STAR Study Group

doi: 10.1093/bjd/ljae287

Melanoma and Skin Cancer

Patient research priorities in melanoma: a national qualitative interview study

Br J Dermatol

Mistry K, Srimudkul O, Patel M, Ragan J, Karponis D, Venables ZC, Levell NJ

doi: 10.1093/bjd/ljaf048

Further Publications Dermatology

Navigating the diagnostic journey of epidermolysis bullosa - a qualitative study on the lived experiences and needs of parents and patients

Br J Dermatol

Korte EWH, Baardman R, Pool G, Duipmans JC, van den Akker PC, Bolling MC

doi: 10.1093/bjd/ljae242

Further Publications Dermatology

Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials

J Eur Acad Dermatol Venereol

Zouboulis CC, Kyrgidis A, Alavi A, Jemec GBE, Martorell A, Marzano AV, van der Zee HH, Wozniak MB, Martinez AL, Kasparek T, Bachhuber T, Ortmann CE, Lobach I, Thomas N, Ravichandran S, Tzellos T

doi: 10.1111/jdv.20369

Further Publications Dermatology

Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burden

J Eur Acad Dermatol Venereol

Ingram JR, Marzano AV, Prens E, Schneider-Burrus S, Warren RB, Keal A, Jha R, Hernandez Daly AC, Kimball AB

doi: 10.1111/jdv.20550

Allergic Diseases

A diverse hidradenitis suppurativa cohort: a retrospective cross-sectional study of 13,130 patients from a large US healthcare system database from 1995-2022

J Am Acad Dermatol

Young K, Loveless I, Su WK, Veenstra J, Yin C, Dimitrion P, Krevh R, Zhou L, She R, Pan M, Levin AM, Young A, Samir E, Dai A, Ge J, Huggins RH, de Guzman Strong C, Lim HW, Ozog DM, Hamzavi I, Adrianto I, Mi QS

doi: 10.1016/j.jaad.2024.10.073

Rheumatoid Arthritis

Association of patient- and hospital-level predictors with patterns of initial treatment in patients with Rheumatoid Arthritis: findings from a national cohort study

Rheumatology (Oxford)

Yang Z, Alveyn E, Russell M, Bechman K, Coalwood C, Price E, Abhishek A, Norton S, Galloway J

doi: 10.1093/rheumatology/keae717

Further Publications Dermatology

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

Lancet

Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, Giamarellos-Bourboulis EJ, Fujita H, Rolleri R, Joshi P, Dokhe P, Muller E, Peterson L, Madden C, Bari M, Zouboulis CC

doi: 10.1016/S0140-6736(24)00101-6

Related content

Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs

A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register

Patient research priorities in melanoma: a national qualitative interview study

Navigating the diagnostic journey of epidermolysis bullosa - a qualitative study on the lived experiences and needs of parents and patients

Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials

Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burden

A diverse hidradenitis suppurativa cohort: a retrospective cross-sectional study of 13,130 patients from a large US healthcare system database from 1995-2022

Association of patient- and hospital-level predictors with patterns of initial treatment in patients with Rheumatoid Arthritis: findings from a national cohort study

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials